Thursday, 12 April 2018
Last week ICN2 Business Development Officer Nadia Pons gave a talk outlining the institute’s spinoff creation policy and encouraged in-house researchers to get involved in entrepreneurial projects. The session was then opened to the whole of the university campus for a presentation by Barcelona Activa to promote its 2018 pre-accelerator programme for business creation.
Monday, 26 March 2018
EMPENTA is the acceleration and support program for technology-based companies promoted by ACCIÓ (Catalan Government) and led by ESADE and ESADECREAPOLIS. In its seventh edition over 130 projects have been registered, doubling the numbers of the previous edition.
Tuesday, 19 December 2017
This initiative, managed by the ICN2 and scientifically coordinated by the ICN2 and ICFO, will promote a strong community to develop cutting-edge graphene technologies for and by Catalan industry. It was presented on 4 December this year at the ICN2, in an event to kick start the creation of a project portfolio that simultaneously drives progress and showcases regional excellence.
Tuesday, 23 January 2018
Ahead Therapeutics SL is the result of a joint research project with a strong nano component between the Germans Trias i Pujol Research Institute (IGTP), the ICN2 and ICREA. It was created to advance the development of therapies for autoimmune diseases and pursue their application in a clinical setting. Just a few months in, the new company has already attracted 1.1 million euros in private investment.
Tuesday, 12 December 2017
In 2012 the ICN2, ICREA and Chemipol signed a licence agreement for the joint development of innovative antifungal paint based on micro- and nanoencapsulation technologies. This technology has been on the market since 2015, and is the third commercial product to emerge from the ICN2.
